Robert Burns
Stock Analyst at H.C. Wainwright
(4.76)
# 626
Out of 5,051 analysts
1078
Total ratings
43.1%
Success rate
17.4%
Average return
Main Sectors:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Reiterated: Buy | $27 | $16.46 | +64.03% | 20 | Oct 13, 2026 | |
| CRBU Caribou Biosciences | Downgraded: Hold | n/a | $0.4969 | - | 31 | Oct 8, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | $35 | $14.95 | +134.11% | 14 | Oct 2, 2026 | |
| BLSM BlossomHill Therapeutics | Reiterated: Buy | $35 | $17.27 | +102.66% | 3 | Sep 30, 2026 | |
| TLX Telix Pharmaceuticals | Reiterated: Buy | $20 | $11.29 | +77.15% | 2 | Sep 30, 2026 | |
| ACET Adicet Bio | Reiterated: Buy | $27 → $34 | $5.53 | +514.83% | 7 | Sep 29, 2026 | |
| COGT Cogent Biosciences | Reiterated: Buy | $55 | $29.78 | +84.69% | 29 | Sep 16, 2026 | |
| CRDF Cardiff Oncology | Upgraded: Buy | $9 | $1.04 | +765.38% | 14 | Sep 15, 2026 | |
| INBX Inhibrx Biosciences | Reiterated: Buy | $245 | $90.53 | +170.63% | 2 | Sep 9, 2026 | |
| PMVP PMV Pharmaceuticals | Reiterated: Buy | $5 | $1.41 | +254.61% | 23 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 → $280 | $193.95 | +44.37% | 47 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $55 | $25.33 | +117.13% | 46 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $1.88 | +1,123.40% | 16 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $29 | $17.98 | +61.29% | 36 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.90 | +426.32% | 8 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $68 | $24.17 | +181.34% | 23 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $25 | $9.25 | +170.27% | 16 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $27 | $11.81 | +128.62% | 49 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $4.90 | +328.57% | 34 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.77 | +521.47% | 42 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $3 | $0.5051 | +493.94% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.74 | +113.90% | 25 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $21 | $2.42 | +767.77% | 8 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $34 | $22.16 | +53.43% | 31 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $65 | $40.84 | +59.16% | 12 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.13 | +228.64% | 23 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.79 | +243.01% | 7 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $59.82 | -6.39% | 25 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.86 | - | 45 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $1.11 | +1,341.44% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 → $35 | $17.34 | +101.85% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $17.33 | +142.35% | 14 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $2.52 | +415.87% | 10 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $4.24 | +65.09% | 4 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.72 | - | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $3.26 | +789.57% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $95.84 | +35.64% | 104 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.38 | - | 23 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $11 | $1.40 | +685.71% | 32 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $13.07 | - | 44 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.74 | +359.77% | 12 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.38 | n/a | 29 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $21.32 | n/a | 8 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 6 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.80 | n/a | 19 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $20 | $0.9499 | n/a | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.80 | n/a | 13 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $24.44 | n/a | 18 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $4.25 | n/a | 7 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $2.42 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $2.43 | n/a | 16 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.08 | n/a | 8 | Mar 5, 2021 |
ArriVent BioPharma
Oct 13, 2026
Reiterated: Buy
Price Target: $27
Current: $16.46
Upside: +64.03%
Caribou Biosciences
Oct 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.4969
Upside: -
Cullinan Therapeutics
Oct 2, 2026
Reiterated: Buy
Price Target: $35
Current: $14.95
Upside: +134.11%
BlossomHill Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $35
Current: $17.27
Upside: +102.66%
Telix Pharmaceuticals
Sep 30, 2026
Reiterated: Buy
Price Target: $20
Current: $11.29
Upside: +77.15%
Adicet Bio
Sep 29, 2026
Reiterated: Buy
Price Target: $27 → $34
Current: $5.53
Upside: +514.83%
Cogent Biosciences
Sep 16, 2026
Reiterated: Buy
Price Target: $55
Current: $29.78
Upside: +84.69%
Cardiff Oncology
Sep 15, 2026
Upgraded: Buy
Price Target: $9
Current: $1.04
Upside: +765.38%
Inhibrx Biosciences
Sep 9, 2026
Reiterated: Buy
Price Target: $245
Current: $90.53
Upside: +170.63%
PMV Pharmaceuticals
Sep 8, 2026
Reiterated: Buy
Price Target: $5
Current: $1.41
Upside: +254.61%
Aug 27, 2026
Reiterated: Buy
Price Target: $195 → $280
Current: $193.95
Upside: +44.37%
Aug 26, 2026
Reiterated: Buy
Price Target: $51 → $55
Current: $25.33
Upside: +117.13%
Aug 21, 2026
Reiterated: Buy
Price Target: $23
Current: $1.88
Upside: +1,123.40%
Aug 21, 2026
Reiterated: Buy
Price Target: $28 → $29
Current: $17.98
Upside: +61.29%
Aug 20, 2026
Reiterated: Buy
Price Target: $10
Current: $1.90
Upside: +426.32%
Aug 18, 2026
Reiterated: Buy
Price Target: $66 → $68
Current: $24.17
Upside: +181.34%
Aug 10, 2026
Reiterated: Buy
Price Target: $20 → $25
Current: $9.25
Upside: +170.27%
Aug 10, 2026
Reiterated: Buy
Price Target: $25 → $27
Current: $11.81
Upside: +128.62%
Aug 7, 2026
Reiterated: Buy
Price Target: $21
Current: $4.90
Upside: +328.57%
Aug 6, 2026
Reiterated: Buy
Price Target: $11
Current: $1.77
Upside: +521.47%
Jul 31, 2026
Downgraded: Hold
Price Target: $13 → $3
Current: $0.5051
Upside: +493.94%
Jul 29, 2026
Reiterated: Buy
Price Target: $8
Current: $3.74
Upside: +113.90%
Jul 20, 2026
Reiterated: Buy
Price Target: $27 → $21
Current: $2.42
Upside: +767.77%
Jul 10, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $22.16
Upside: +53.43%
Jul 9, 2026
Reiterated: Buy
Price Target: $56 → $65
Current: $40.84
Upside: +59.16%
Jul 9, 2026
Reiterated: Buy
Price Target: $7
Current: $2.13
Upside: +228.64%
Jul 6, 2026
Reiterated: Buy
Price Target: $13
Current: $3.79
Upside: +243.01%
Jul 2, 2026
Reiterated: Buy
Price Target: $56
Current: $59.82
Upside: -6.39%
Jun 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.86
Upside: -
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $1.11
Upside: +1,341.44%
Jun 3, 2026
Rated: Buy
Price Target: $33 → $35
Current: $17.34
Upside: +101.85%
Jun 1, 2026
Reiterated: Buy
Price Target: $42
Current: $17.33
Upside: +142.35%
Jun 1, 2026
Reiterated: Buy
Price Target: $13
Current: $2.52
Upside: +415.87%
May 28, 2026
Reiterated: Buy
Price Target: $7
Current: $4.24
Upside: +65.09%
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.72
Upside: -
May 1, 2026
Reiterated: Buy
Price Target: $29
Current: $3.26
Upside: +789.57%
Apr 27, 2026
Reiterated: Buy
Price Target: $130
Current: $95.84
Upside: +35.64%
Apr 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.38
Upside: -
Apr 16, 2026
Reiterated: Buy
Price Target: $8 → $11
Current: $1.40
Upside: +685.71%
Apr 13, 2026
Downgraded: Sell
Price Target: n/a
Current: $13.07
Upside: -
Feb 13, 2026
Reiterated: Buy
Price Target: $8
Current: $1.74
Upside: +359.77%
Aug 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.38
Upside: n/a
Sep 3, 2024
Rated: Hold
Price Target: n/a
Current: $21.32
Upside: n/a
Jul 16, 2024
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
May 24, 2024
Rated: Hold
Price Target: n/a
Current: $6.80
Upside: n/a
Mar 21, 2024
Reiterated: Buy
Price Target: $110 → $20
Current: $0.9499
Upside: n/a
Jan 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $3.80
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $24.44
Upside: n/a
Mar 17, 2023
Reiterated: Buy
Price Target: $22
Current: $4.25
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $11
Current: $2.42
Upside: n/a
Oct 22, 2021
Reiterated: Sell
Price Target: n/a
Current: $2.43
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $10
Current: $1.08
Upside: n/a